PQUS0.820%
as of Sep 1
CI
GrowthTHE CIGNA GROUP
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes.
Close · 3M
-0.02%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals5
Win rate20% (1/5)
Avg buy return-2.08%
PQUS · Weight decrease · 3d
weight 0.850% → 0.810% (-0.040 pp)·stock down 3.1% in the 30 days before
Aug 29·entry $276.08·now $282.52
+2.33%
since Aug 29
PQUS · Weight decrease · 2d
weight 0.850% → 0.830% (-0.020 pp)·stock down 3.1% in the 30 days before
Aug 28·entry $278.88·now $282.52
+1.31%
since Aug 28
PQUS · Weight decrease · 2d
weight 0.640% → 0.620% (-0.020 pp)·stock down 6.7% in the 30 days before
Aug 13·entry $277.99·now $282.52
+1.63%
since Aug 13
PQUS · Weight increase · 2d
weight 0.250% → 0.640% (+0.390 pp)·stock down 3.2% in the 30 days before
Aug 8·entry $278.40·now $282.52Fresh
+1.48%
since Aug 8
PQUS · Sudden change · 1d
weight 0.250% → 0.630% (+0.380 pp)·stock down 3.2% in the 30 days before
Aug 7·entry $282.49·now $282.52
+0.01%
since Aug 7
PQUS · Weight decrease · 2d
weight 0.320% → 0.290% (-0.030 pp)·stock up 0.7% in the 30 days before
Aug 2·entry $282.06·now $282.52
+0.16%
since Aug 2
PQUS · Weight increase · 2d
weight 0.290% → 0.310% (+0.020 pp)·stock up 3.6% in the 30 days before
Jul 26·entry $291.02·now $282.52Fresh
-2.92%
since Jul 26
PQUS · Weight decrease · 2d
weight 0.320% → 0.300% (-0.020 pp)·stock up 5.5% in the 30 days before
Jul 2·entry $287.77·now $282.52
-1.82%
since Jul 2
PQUS · Weight increase · 2d
weight 0.320% → 0.340% (+0.020 pp)·stock down 0.9% in the 30 days before
Jun 12·entry $298.00·now $282.52Fresh
-5.19%
since Jun 12
PQUS · Weight increase · 2d
weight 0.300% → 0.320% (+0.020 pp)·stock up 2.7% in the 30 days before
Jun 7·entry $289.61·now $282.52Fresh
-2.45%
since Jun 7
PQUS · New entry · 1d
weight 0 → 0.070% (new)·stock up 2.3% in the 30 days before
May 22·entry $286.24·now $282.52Fresh
-1.30%
since May 22
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
Fails the frameworkas of Aug 30
AI ETFs PQUS and QRFT currently hold Cigna, with PQUS showing a recent trend of decreasing its weight. This contrasts with our 'Fail' verdict, which indicates the company cannot be fully endorsed by the framework due to critical missing information on management, complete financial health, and a quantifiable margin of safety, suggesting AI's rationale for holding (or decreasing) differs from a complete Buffett-style assessment.
- Circle of CompetenceThe Cigna Group, as a large, established healthcare services provider, operates within an industry with generally predictable unit economics regarding premiums, claims, and administrative costs, making its earning power reasonably projectable.
- Economic MoatCigna likely benefits from durable competitive advantages such as scale-driven cost advantages in negotiating with providers and pharmaceutical companies, high switching costs for employers and individuals, and significant regulatory barriers to entry.
- ManagementInformation on management's candor, capital allocation discipline (beyond current ROE), or skin in the game is not provided in the available data, preventing a full assessment.
- Financial HealthWhile the current ROE of 15.24% is strong, comprehensive data on 10-year average ROE, stable operating margins, manageable debt levels (beyond EV/EBITDA), and explicit owner earnings figures are not available to fully satisfy this stage's criteria.
- Margin of SafetyWithout sufficient data to project ten-year cash flows and estimate intrinsic value, it is not possible to determine if the current price offers a defensible margin of safety.
The Cigna Group passes the initial stages of the framework, appearing to be within the circle of competence with a durable economic moat. However, key information regarding management quality, a comprehensive view of long-term financial health, and a quantifiable margin of safety are absent from the provided data. Due to these unconfirmable yet critical criteria, the analysis yields a 'Fail' verdict, as all stages cannot be conclusively passed.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.